Cargando…

RIPK1 is a negative mediator in Aquaporin 1-driven triple-negative breast carcinoma progression and metastasis

The triple-negative breast carcinoma (TNBC) is the most aggressive subtype of breast cancer. In TNBC, Aquaporin 1 (AQP1), a water-transporting transmembrane protein, is aberrantly enriched in cytoplasm and causes tumor cell death evasion. However, the carcinogenetic bioactivities of cytoplasmic AQP1...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yin, Zhuming, Chen, Wenlin, Yin, Jian, Sun, Jingyan, Xie, Qianrong, Wu, Min, Zeng, Fanxin, Ren, Huiwen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8115349/ https://www.ncbi.nlm.nih.gov/pubmed/33980862 http://dx.doi.org/10.1038/s41523-021-00261-5

Ejemplares similares

Aquaporin 1 knockdown inhibits triple-negative breast cancer cell proliferation and invasion in vitro and in vivo
por: Ji, Yinan, et al.
Publicado: (2021)

RIPK1-dependent necroptosis promotes vasculogenic mimicry formation via eIF4E in triple-negative breast cancer
por: Li, Fan, et al.
Publicado: (2023)

OSW‐1 inhibits tumor growth and metastasis by NFATc2 on triple‐negative breast cancer
por: Ding, Xiaorong, et al.
Publicado: (2020)

CDK16 promotes the progression and metastasis of triple-negative breast cancer by phosphorylating PRC1
por: Li, Xiao, et al.
Publicado: (2022)

GPR110 promotes progression and metastasis of triple-negative breast cancer
por: Nam, Hye-Jung, et al.
Publicado: (2022)

Correction: RIPK1-dependent necroptosis promotes vasculogenic mimicry formation via eIF4E in triple-negative breast cancer
por: Li, Fan, et al.
Publicado: (2023)

Potassium channel-driven bioelectric signalling regulates metastasis in triple-negative breast cancer
por: Payne, Samantha L., et al.
Publicado: (2021)

Molecular Characteristics and Metastasis Predictor Genes of Triple-Negative Breast Cancer: A Clinical Study of Triple-Negative Breast Carcinomas
por: Kuo, Wen-Hung, et al.
Publicado: (2012)

Decreased RIPK1 expression in chondrocytes alleviates osteoarthritis via the TRIF/MyD88-RIPK1-TRAF2 negative feedback loop
por: Liang, Shuang, et al.
Publicado: (2019)

Triple-negative breast cancer molecular subtyping and treatment progress
por: Yin, Li, et al.
Publicado: (2020)

Dual complementary liposomes inhibit triple-negative breast tumor progression and metastasis
por: Guo, Peng, et al.
Publicado: (2019)

Correction: GPR110 promotes progression and metastasis of triple-negative breast cancer
por: Nam, Hye-Jung, et al.
Publicado: (2022)

Primidone blocks RIPK1-driven cell death and inflammation
por: Riebeling, Theresa, et al.
Publicado: (2020)

Anomanolide C suppresses tumor progression and metastasis by ubiquitinating GPX4-driven autophagy-dependent ferroptosis in triple negative breast cancer
por: Chen, Yan-Mei, et al.
Publicado: (2023)

TRAF6 regulates the abundance of RIPK1 and inhibits the RIPK1/RIPK3/MLKL necroptosis signaling pathway and affects the progression of colorectal cancer
por: Lin, Penghang, et al.
Publicado: (2023)

The role of EMT-related lncRNA in the process of triple-negative breast cancer metastasis
por: Zhang, Haomeng, et al.
Publicado: (2021)

Targeting hypoxia regulated sodium driven bicarbonate transporters reduces triple negative breast cancer metastasis
por: Carroll, Christopher Paul, et al.
Publicado: (2022)

The potential role of cofilin-1 in promoting triple negative breast cancer (TNBC) metastasis via the extracellular vesicles (EVs)
por: Howard, Jane, et al.
Publicado: (2021)

CCAT1 promotes triple-negative breast cancer progression by suppressing miR-218/ZFX signaling
por: Han, Chunyong, et al.
Publicado: (2019)

Gastric Metastasis of Triple Negative Invasive Lobular Carcinoma
por: Geredeli, Caglayan, et al.
Publicado: (2015)

SENP1 prevents steatohepatitis by suppressing RIPK1-driven apoptosis and inflammation
por: Yan, Lingjie, et al.
Publicado: (2022)

Triple negative breast cancer: Pitfalls and progress
por: Zagami, Paola, et al.
Publicado: (2022)

Therapeutic progress and challenges for triple negative breast cancer: targeted therapy and immunotherapy
por: Yang, Ruoning, et al.
Publicado: (2022)

The Role of RIPK1 and RIPK3 in Cardiovascular Disease
por: DeRoo, Elise, et al.
Publicado: (2020)

MCP-1 is overexpressed in triple-negative breast cancers and drives cancer invasiveness and metastasis
por: Dutta, Pranabananda, et al.
Publicado: (2018)

SIPA1 Regulates LINC01615 to Promote Metastasis in Triple-Negative Breast Cancer
por: Xiang, Yuan, et al.
Publicado: (2022)

β1 Integrin as a Prognostic and Predictive Marker in Triple-Negative Breast Cancer
por: Yin, Hsin-Ling, et al.
Publicado: (2016)

Increased Expression Levels of WAVE3 Are Associated with the Progression and Metastasis of Triple Negative Breast Cancer
por: Kulkarni, Swati, et al.
Publicado: (2012)

The small G-protein RalA promotes progression and metastasis of triple-negative breast cancer
por: Thies, Katie A., et al.
Publicado: (2021)

Metabotropic Glutamate Receptor-1 Contributes to Progression in Triple Negative Breast Cancer
por: Banda, Malathi, et al.
Publicado: (2014)

LncRNAs as new biomarkers to differentiate triple negative breast cancer from non-triple negative breast cancer
por: Lv, Mingming, et al.
Publicado: (2016)

Follistatin-like 1 deficiency impairs T cell development to promote lung metastasis of triple negative breast cancer
por: Ma, Jie, et al.
Publicado: (2021)

Rad51 supports triple negative breast cancer metastasis
por: Wiegmans, Adrian P, et al.
Publicado: (2014)

Wnt signaling in triple negative breast cancer is associated with metastasis
por: Dey, Nandini, et al.
Publicado: (2013)

Ripk1 and haematopoiesis: a case for LUBAC and Ripk3
por: Annibaldi, Alessandro, et al.
Publicado: (2018)

PD-1 Independent Role of PD-L1 in Triple-Negative Breast Cancer Progression
por: Alkaabi, Duaa, et al.
Publicado: (2023)

SphK2/S1P Promotes Metastasis of Triple-Negative Breast Cancer Through the PAK1/LIMK1/Cofilin1 Signaling Pathway
por: Shi, Weiwei, et al.
Publicado: (2021)

LncRNA FAM83H-AS1 promotes triple-negative breast cancer progression by regulating the miR-136-5p/metadherin axis
por: Han, Chunyong, et al.
Publicado: (2020)

The oncogenic miR-429 promotes triple-negative breast cancer progression by degrading DLC1
por: Li, Yao, et al.
Publicado: (2023)

RIPK1 activation mediates neuroinflammation and disease progression in multiple sclerosis
por: Zelic, Matija, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kdjfap2dv6pinjtd6kr8vmkqcc